Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01247064 · ClinicalTrials.gov registry record · Phase 4
Hypertonic Saline for Acute Bronchiolitis
A Phase 4 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT01247064 is a Phase 4 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 62 participants.
The verdict
NCT01247064, a Phase 4 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS) improves respiratory distress in children 2-23 months presenting to the emergency department (ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with a trial of nebulized albuterol.
Interventions
- DRUG Nebulized 3% saline
- DRUG Nebulized 0.9% Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01247064
The ClinicalTrials.gov registry entry for NCT01247064 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nebulized 3% saline is the first listed.
NCT01247064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01247064 about?
NCT01247064 is a clinical study titled "Hypertonic Saline for Acute Bronchiolitis". The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS) improves respiratory distress in children 2-23 months presenting to the emergency department (ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with a trial of nebulized albute...
What is the current status of trial NCT01247064?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2010-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01247064?
The interventions under investigation include: Nebulized 3% saline (DRUG), Nebulized 0.9% Normal Saline (DRUG).
Who is sponsoring clinical trial NCT01247064?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.